Changing the world
UCLB is the commercialisation company of UCL and its partner NHS Trusts. We bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives.
£438 million investment for UCL gene therapy spinouts
UCL spinout Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, has raised $225 million (£173 million) through its initial public offering. The funding success adds to an unprecedented summer that saw UCL spinout companies raise £265 million of investment which could transform patient outcomes.
Novel method of analysis of stroke data
Latest news and highlights
Bringing innovation to life